Literature DB >> 8379937

The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation.

M I Mackness1, C Abbott, S Arrol, P N Durrington.   

Abstract

1. The oxidation of low-density lipoprotein (LDL) is believed to play a central role in atherogenesis. We have compared the effect of antioxidant vitamins and high-density lipoprotein (HDL) on the Cu(2+)-catalysed oxidation of LDL. 2. Antioxidant vitamin supplementation significantly reduced conjugated diene formation but did not affect the formation of lipid peroxides. 3. Conversely, HDL did not affect conjugated diene formation but inhibited the formation of lipid peroxides by up to 90%. 4. The inhibition by HDL of lipid peroxide formation in oxidized LDL was dependent on the concentration of HDL and was not due to HDL chelating Cu2+. 5. Large interindividual variations in the inhibition of lipid peroxide formation by autologous HDL were evident, which were related to the rate of lipid peroxide generation in the LDL. 6. We conclude that HDL is a powerful antioxidant or more probably inhibitor of LDL oxidation in vitro and may play an important role in vivo in preventing atherosclerosis by inhibiting LDL oxidation in the artery wall.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8379937      PMCID: PMC1134536          DOI: 10.1042/bj2940829

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

2.  Comparison of two commercial nephelometric methods for apoprotein A-I and apoprotein B with standardized apoprotein A-I and B radioimmunoassays.

Authors:  J L Adolphson; J J Albers
Journal:  J Lipid Res       Date:  1989-04       Impact factor: 5.922

3.  A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent.

Authors:  M el-Saadani; H Esterbauer; M el-Sayed; M Goher; A Y Nassar; G Jürgens
Journal:  J Lipid Res       Date:  1989-04       Impact factor: 5.922

4.  [Protective effect of high density lipoproteins, their subfractions and lecithin-cholesterol-acyltransferases on the peroxidation modification of low density lipoproteins].

Authors:  A N Klimov; A A Nikiforova; V M Pleskov; A A Kuz'min; N N Kalashnikova
Journal:  Biokhimiia       Date:  1989-01

Review 5.  High density lipoprotein metabolism.

Authors:  S Eisenberg
Journal:  J Lipid Res       Date:  1984-10       Impact factor: 5.922

6.  Lipolytic surface remnants of triglyceride-rich lipoproteins are cytotoxic to macrophages but not in the presence of high density lipoprotein. A possible mechanism of atherogenesis?

Authors:  B H Chung; J P Segrest; K Smith; F M Griffin; C G Brouillette
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

7.  Lipid peroxides and atherosclerosis.

Authors:  M D Stringer; P G Görög; A Freeman; V V Kakkar
Journal:  BMJ       Date:  1989-02-04

8.  Increased diene conjugates in diabetic subjects with microangiopathy.

Authors:  P E Jennings; A F Jones; C M Florkowski; J Lunec; A H Barnett
Journal:  Diabet Med       Date:  1987 Sep-Oct       Impact factor: 4.359

9.  Plasma triglycerides related decrease in high-density lipoprotein cholesterol and its association with myocardial infarction in heterozygous familial hypercholesterolemia.

Authors:  S Moorjani; C Gagné; P J Lupien; D Brun
Journal:  Metabolism       Date:  1986-04       Impact factor: 8.694

Review 10.  High-density lipoprotein cholesterol: methods and clinical significance.

Authors:  P N Durrington
Journal:  Crit Rev Clin Lab Sci       Date:  1982       Impact factor: 6.250

View more
  34 in total

1.  Insecticides and atherosclerosis.

Authors:  F C Luft
Journal:  J Mol Med (Berl)       Date:  2001-08       Impact factor: 4.599

2.  Oxidative modification and poor protective activity of HDL on LDL oxidation in thalassemia.

Authors:  Supeenun Unchern; Narumon Laohareungpanya; Yupin Sanvarinda; Kovit Pattanapanyasat; Pansakorn Tanratana; Udom Chantharaksri; Nathawut Sibmooh
Journal:  Lipids       Date:  2010-06-09       Impact factor: 1.880

Review 3.  Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy.

Authors:  Richard J Woodman; Gerard T Chew; Gerald F Watts
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  The paraoxonase gene family and atherosclerosis.

Authors:  David Seo; Pascal Goldschmidt-Clermont
Journal:  Curr Atheroscler Rep       Date:  2009-05       Impact factor: 5.113

5.  Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.

Authors:  M Navab; S Hama-Levy; B J Van Lenten; G C Fonarow; C J Cardinez; L W Castellani; M L Brennan; A J Lusis; A M Fogelman; B N La Du
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

6.  Dietary Aloe vera improves plasma lipid profile, antioxidant, and hepatoprotective enzyme activities in GIFT-tilapia (Oreochromis niloticus) after Streptococcus iniae challenge.

Authors:  Ndakalimwe Naftal Gabriel; Jun Qiang; Xin Yu Ma; Jie He; Pao Xu; Kai Liu
Journal:  Fish Physiol Biochem       Date:  2015-06-25       Impact factor: 2.794

Review 7.  LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: role of prooxidants vs. antioxidants.

Authors:  M Aviram; B Fuhrman
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

8.  Paraoxonase: Its antiatherogenic role in chronic renal failure.

Authors:  M Prakash; N M Phani; R Kavya; M Supriya
Journal:  Indian J Nephrol       Date:  2010-01

9.  Paraoxonase Activity and Lipid Profile in Paediatric Nephrotic Syndrome: A Cross-sectional Study.

Authors:  Vijayetha P Patil; Anuradha B Patil; Vidya S Patil; Deepti G Ingleshwar
Journal:  J Clin Diagn Res       Date:  2016-03-01

10.  High prevalence of low serum paraoxonase-1 in subjects with coronary artery disease.

Authors:  Narayani Jayakumari; Gopalan Thejaseebai
Journal:  J Clin Biochem Nutr       Date:  2009-10-28       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.